News
03-15-2010, 06:24 AM
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the “bystander effect” in treating metastatic melanoma. Dr. Agarwala’s presentation, entitled “Chemoablation in Melanoma: An Update,” was given in the session entitled “Unique Approaches to Melanoma Therapy.”
More... (http://www.news-medical.net/news/20100315/Metastatic-melanoma-Involvement-of-immune-system-in-response-to-PV-10-therapy.aspx)
More... (http://www.news-medical.net/news/20100315/Metastatic-melanoma-Involvement-of-immune-system-in-response-to-PV-10-therapy.aspx)